Microbial restoration of the inflamed gut

Fecal transplantation as alternative therapy for a common disease?

2013-10-01

(Press-News.org) This news release is available in German and German.

About two million people in Europe suffer from chronic inflammatory bowel diseases, which are characterized by progressive tissue destruction and that often necessitate removal of sections of the intestine. The exact causes of Crohn's disease and ulcerative colitis, the most common forms of these diseases, are still largely unknown. In addition to genetic and environmental as well as lifestyle factors, a disturbed intestinal microbiota is responsible for triggering the disease. Complete recovery is often not possible. "If drug therapies fail, removal of parts of the inflamed intestine is currently the last treatment option," said Walter Reinisch, a gastroenterologist at the University Clinic for Internal Medicine III, Medical University of Vienna, and initiator of the study.

Fecal transplantation: an alternative therapy with a certain "yuck" factor

The idea of the transfer of fecal matter naturally causes some disgust. However, in many infectious and chronic diarrheas the intestinal microbiota is massively disrupted and it is therefore fecal transplantation can be used to restore the natural intestinal microbiota and thereby improve disease state. "Meta studies have shown that the controlled grafting of fecal transplantation from healthy donors is a safe and very effective treatment of acute diarrheal diseases caused by the pathogenic bacterium Clostridium difficile," said Sieglinde Angelberger, gastroenterologist at the University Clinic for Internal Medicine III of the Medical University of Vienna and author of the study: "this was the reason why we applied this therapy for the treatment of patients with chronic intestinal diseases."

Successive colonization by donor intestinal bacteria

"So far, it has not been sufficiently tested whether and how successful fecal transplantation is for the permanent settlement of microbiota from a healthy donor to a patient," said Alexander Loy of the Department of Microbiology and Ecosystem Research, University of Vienna. "That is why we have followed the composition of the intestinal microbiota of patients using modern DNA sequencing methods over a period of up to three months after treatment."

The intestinal ecosystem of each individual patient reacted very differently to the fecal transplantation. Intestinal bacteria of the donors were detected in the patients, but at different times and in different frequencies. "Although we don't know the mechanisms yet, repopulation of the gut by bacteria appears to analogous to succession in a forest after it is damaged in a storm," said microbiologist David Berry: "pioneer species colonize the deforested area, in this case the inflamed intestine, and alter the ecosystem in a way that lets other species colonize and eventually a complex ecosystem can be restored."

Cooperation between basic research and applied medicine

"Working with the Medical University of Vienna offered us an opportunity to translate fundamental science expertise from the project InflammoBiota to study the intestinal microbiota of patients," said Alexander Loy. The joint project InflammoBiota, which was dedicated to the study of immunology and the microbial causes of inflammatory bowel disease, was funded by the Austrian Genome Research Programme GEN-AU of the Federal Ministry for Science and Research.

INFORMATION:

Publication in American Journal of Gastroenterology

Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation By: Sieglinde Angelberger, Walter Reinisch, Athanasios Makristathis, Cornelia Lichtenberger, Clemens Dejaco, Pavol Papay, Gottfried Novacek, Michael Trauner, Alexander Loy and David Berry. In: American Journal of Gastroenteroloy (AJG), September 2013. http://www.nature.com/ajg/journal/vaop/ncurrent/full/ajg2013257a.html

Participating Institutions

Division of Microbial Ecology, Department of Microbiology and Ecosystem Research, Faculty of Life Sciences, University of Vienna Department of Clinical Microbiology and Division of Gastroenterology and Hepatology, Medical University of Vienna

ELSE PRESS RELEASES FROM THIS DATE:

New findings on combined radiation injury from nuclear disaster

2013-10-01

MAYWOOD, Il. – A nuclear bomb or nuclear reactor accident can produce a deadly combination of radiation exposure and injuries such as burns and trauma. Now the first study of its kind in 50 years is providing new insights into this phenomenon, called combined radiation injury (CRI). Researchers at Loyola University Chicago Stritch School of Medicine have shown how CRI causes the intestines to leak bacteria into surrounding tissue. The study also showed that radiation and burns have a synergistic effect that make them far more deadly when they act in combination. The ...

'Waviness' explains why carbon nanotube forests have low stiffness

2013-10-01

A new study has found that "waviness" in forests of vertically-aligned carbon nanotubes dramatically reduces their stiffness, answering a long-standing question surrounding the tiny structures. Instead of being a detriment, the waviness may make the nanotube arrays more compliant and therefore useful as thermal interface material for conducting heat away from future high-powered integrated circuits. Measurements of nanotube stiffness, which is influenced by a property known as modulus, had suggested that forests of vertically-aligned nanotubes should have a much higher ...

ForWarn follows rapidly changing forest conditions

2013-10-01

U.S. Forest Service and partner scientists are keeping a watchful eye on forest health. As fall colors replace the lush greenness of spring and summer, researchers recognize telltale signs of change in healthy forests. A new publication highlights specific examples where researchers have used ForWarn, a state-of-the-art forest change recognition and tracking system, to detect disturbances and track forest recovery. ForWarn uses NASA satellite imagery to develop real-time maps that assist forest managers in the continental United States. Since 2010, ForWarn has detected ...

JCI early table of contents for Oct. 1, 2013

2013-10-01

Hemin and sickle cell disease-associated acute chest syndrome development Acute chest syndrome (ACS) is a complication of sickle cell disease that is characterized by sudden pain and difficulty breathing. Sickle cell disease can also cause red blood cells to suddenly breakdown and release their contents, which may trigger the onset of ACS. In this issue of the Journal of Clinical Investigation, Solomon Fiifi Ofori-Acquah and colleagues at Emory University asked if hemin, a product released by red blood cells during lysis, triggers ACS in a mouse model of sickle cell ...

Hemin and sickle cell disease-associated acute chest syndrome development

2013-10-01

Acute chest syndrome (ACS) is a complication of sickle cell disease that is characterized by sudden pain and difficulty breathing. Sickle cell disease can also cause red blood cells to suddenly breakdown and release their contents, which may trigger the onset of ACS. In this issue of the Journal of Clinical Investigation, Solomon Fiifi Ofori-Acquah and colleagues at Emory University asked if hemin, a product released by red blood cells during lysis, triggers ACS in a mouse model of sickle cell disease. They found that hemin injection caused labored breathing, acute lung ...

A link between type 2 diabetes and mitochondrial function

2013-10-01

Type 2 diabetes is a chronic condition that is characterized by resistance to or insufficient production of insulin, a hormone that controls sugar movement into cells. In certain tissues, insulin resistance has been associated with dysfunction of mitochondria, which supply most of the cell's chemical energy. In this issue of the Journal of Clinical Investigation, C. Ronald Kahn and colleagues at Harvard Medical School evaluated mitochondrial involvement in insulin resistance. They found that heat shock protein 60 (HSP60), which is involved in mitochondrial protein import ...

Scientists who share data publicly receive more citations

2013-10-01

A new study finds that papers with data shared in public gene expression archives received increased numbers of citations for at least five years. The large size of the study allowed the researchers to exclude confounding factors that have plagued prior studies of the effect and to spot a trend of increasing dataset reuse over time. The findings will be important in persuading scientists that they can benefit directly from publicly sharing their data. The study, which adds to growing evidence for an open data citation benefit across different scientific fields, is entitled ...

Report: Breast cancer incidence rates converging among white and African-American women

2013-10-01

ATLANTA -- Breast cancer incidence rates increased slightly among African American women from 2006 to 2010, bringing those rates closer to the historically higher rates among white women, according to a new analysis by American Cancer Society researchers. The explanation behind the rise is unclear. The finding is published in Breast Cancer Statistics, 2013 published in CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society. The report and its consumer version, Breast Cancer Facts & Figures 2013-2014, are published biennially and provide ...

Statin medications may prevent dementia and memory loss with longer use

2013-10-01

A review of dozens of studies on the use of statin medications to prevent heart attacks shows that the commonly prescribed drugs pose no threat to short-term memory, and that they may even protect against dementia when taken for more than one year. The Johns Hopkins researchers who conducted the systematic review say the results should offer more clarity and reassurance to patients and the doctors who prescribe the statin medications. The question of whether statins can cause cognition problems has become a hot topic among cardiologists and their patients following changes ...

Blood-pressure drug may help improve cancer treatment

2013-10-01

Use of existing, well-established hypertension drugs could improve the outcome of cancer chemotherapy by opening up collapsed blood vessels in solid tumors. In their report in the online journal Nature Communications, Massachusetts General Hospital (MGH) investigators describe how the angiotensin inhibitor losartan improved the delivery of chemotherapy drugs and oxygen throughout tumors by increasing blood flow in mouse models of breast and pancreatic cancer. A clinical trial based on the findings of this study is now underway. "Angiotensin inhibitors are safe blood ...

Microbial restoration of the inflamed gut

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: